. LovelandSM, LewinJJ3rd, AmabileCM, StrangeC, MazurJE. Obese man treated with drotrecogin alfa (activated) (letter). Ann Pharmacother2003; 37: 918–9. DOI 10.1345/aph.1C478
2.
. MaciasWL, DhainautJ-F, YanSCB, SegerM, JohnsonG, SmallD. Pharmacokinetic—pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis. J Clin Pharmacol Ther2002; 72: 391–402.
3.
. BartonP, KalilAC, NadelS, GoldsteinB, Okhuysen-CawleyR, BrilliJ, Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics2004; 113 (1): 7–17.